GlassScriptPhysician profile
Pietro G Pecci
NPI 1366510356
$1,298.99
in general payments reported to CMS, 2019-2025
14 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.87 · 2020: $41.18 · 2021: $173 · 2022: $345 · 2023: $188 · 2024: $318 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $565 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $564.86 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $240.57 | 2021-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $205.28 | 2022-2024 | Eliquis |
| Merck Sharp & Dohme LLC | $205.16 | 2019-2025 | Zerbaxa, Verquvo |
| Astellas Pharma US INC | $161.76 | 2024-2025 | Cresemba |
| Novartis Pharmaceuticals Corporation | $128.12 | 2019-2024 | |
| Ucb, INC. | $71.20 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.59 | 2022-2024 | Jardiance |
| Pfizer INC. | $51.02 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $40.70 | 2024 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $40.69 | 2022 | |
| Xeris Pharmaceuticals, INC. | $24.37 | 2022 | |
| La Jolla Pharmaceutical Company | $21.39 | 2023 | Giapreza |
| Abbott Laboratories | $21.07 | 2019 | |
| Vyera Pharmaceuticals, LLC | $21.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pietro Pecci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.